FP
BIIB icon

Factorial Partners’s Biogen BIIB Stock Holding History

Factorial Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,850
Closed -$1.63M – 90
2023
Q1 		$1.63M Buy
5,850
+450
+8% +$125K 1.23% 29
2022
Q4 		$1.5M Sell
5,400
-1,650
-23% -$466K 1.14% 33
2022
Q3 		$1.88M Sell
7,050
-1,800
-20% -$382K 1.63% 20
2022
Q2 		$1.8M Buy
8,850
+1,200
+16% +$245K 1.47% 25
2022
Q1 		$1.61M Buy
7,650
+2,450
+47% +$533K 1.11% 32
2021
Q4 		$1.25M Buy
5,200
+750
+17% +$193K 0.83% 44
2021
Q3 		$1.26M Buy
4,450
+2,550
+134% +$836K 0.86% 42
2021
Q2 		$658K Sell
1,900
-7,300
-79% -$2.21M 0.44% 71
2021
Q1 		$2.57M Sell
9,200
-1,500
-14% -$405K 1.81% 18
2020
Q4 		$2.62M Sell
10,700
-850
-7% -$219K 2.19% 12
2020
Q3 		$3.28M Hold
11,550
– – 3.35% 5
2020
Q2 		$3.09M Buy
11,550
+900
+8% +$271K 3.39% 5
2020
Q1 		$3.37M Sell
10,650
-15,550
-59% -$4.72M 4.49% 2
2019
Q4 		$6.84M Buy
26,200
+11,550
+79% +$3.2M 3.13% 5
2019
Q3 		$3.41M Buy
14,650
+1,400
+11% +$326K 3.28% 5
2019
Q2 		$3.1M Buy
13,250
+5,000
+61% +$1.15M 2.97% 5
2019
Q1 		$1.95M Buy
+8,250
New +$2.6M 1.84% 13

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Factorial Partners's BIIB Position: Q2 2023 in Review

Factorial Partners sold out of Biogen (BIIB) in Q2 2023, closing a stake of 5,850 shares — an estimated $1.63M sold.

Factorial Partners first reported a position in BIIB in Q1 2019 and held it in 17 quarters. The position peaked at $6.84M in Q4 2019. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Factorial Partners reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Factorial Partners sold 5,850 Biogen shares in Q2 2023, an estimated $1.63M.
  • Factorial Partners first reported a position in Biogen in Q1 2019 and held it in 17 quarters.
  • Factorial Partners's Biogen position peaked at $6.84M in Q4 2019.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Factorial Partners's 13F filing for Q2 2023, filed 2 Aug 2023.